Oxychlororaphine
CAS No. 550-89-0
Oxychlororaphine ( phenazine-1-carboxamide )
产品货号. M28110 CAS No. 550-89-0
氧氯拉芬强烈抑制链霉菌属的生长。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥275 | 有现货 |
|
5MG | ¥446 | 有现货 |
|
10MG | ¥761 | 有现货 |
|
25MG | ¥1596 | 有现货 |
|
50MG | ¥2657 | 有现货 |
|
100MG | ¥4277 | 有现货 |
|
500MG | ¥9639 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Oxychlororaphine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述氧氯拉芬强烈抑制链霉菌属的生长。
-
产品描述Oxychlororaphine inhibits strongly the growth of Streptomyces sp. 441.
-
体外实验Oxychloroaphine (1-256 μM; 24 h) has cytotoxicity with IC50 values for A549, HeLa, and SW480 cancer cell lines between 32 and 40 μM.Oxychloroaphine (1-150 μM; A549, HeLa, and SW480 cancer cell lines) causes cell membrane damage, leading to increase apoptosis and leakage of lactate dehydrogenase, and increases production of cytochrome c protein.Oxychloroaphine (32 μM; A549 and SW480 cells) induces cycle arrest at G1 phase and induction of sub-G phase.Oxychloroaphine (48 h; A549 cells) induces downregulation of antiapoptotic Bcl-2 protein and the activation of proapoptotic protein caspase-3 led to the cleavage of PARP. Cell Viability AssayCell Line:A549, HeLa, and SW480 cancer cell lines Concentration:1, 2, 4, 8, 16, 32, 64, 128, and 256 μM Incubation Time:24 hours Result:Inhibited cell proliferative in a dose-dependent manner.
-
体内实验——
-
同义词phenazine-1-carboxamide
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Carboxylesterase
-
研究领域——
-
适应症——
化学信息
-
CAS Number550-89-0
-
分子量223.235
-
分子式C13H9N3O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 10 mg/mL (44.80 mM)
-
SMILESNC(=O)c1cccc2nc3ccccc3nc12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Sztanke K. Synthesis of new derivatives of 8-aryl-3-phenyl-6,7-dihydro-4H-imidazo[2, 1-c][1,2,4]triazin-4-one. Acta Pol Pharm. 2004 Sep-Oct;61(5):373-7.
产品手册
关联产品
-
ANT3310
ANT3310 是一种广谱共价丝氨酸 β-内酰胺酶抑制剂,对 AmpC、CTX-M-15、TEM-1、OXA-48、OXA-23 和 KPC-2 的 IC50 范围为 1 nM 至 175 nM。 ANT3310可用于细菌感染的研究。
-
Contezolid
Contezolid (MRX I) 是一种口服活性恶唑烷酮化合物,对革兰氏阳性病原体具有抗菌活性,包括 MRSA、青霉素-PRSP、PISP 和耐万古霉素肠球菌 (VRE),MIC 为 0.25-4 ug/mL。
-
LL-37, Human
LL-37, Human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity.